Now on ScienceBlogs: Freethinker Sunday Sermonette: more religion and child abuse

Seed Media Group

Terra Sigillata

musings on medicines from the Earth

Profile

Pharmboy3%20wineless%20150px.jpg Abel Pharmboy is the nom de plume of an academic researcher and educator who took his PhD in Pharmacology and Therapeutics and BS in Toxicology. He writes on natural product drugs and dietary supplements, academic career development, medical journalism and, occasionally, making and listening to music and, with the help of his colleague, Erleichda, wine appreciation.

"Why Terra Sigillata?" will tell you more about the origin of the blog name.

Please read the DISCLAIMER for details on the blog's intended audience, advertising and comment policy, and how not to use the information presented herein.

Social Media Challenge!



This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information: Verify here.


Recent Posts

Recent Comments

Search This Blog

Archives



 Subscribe in a reader

Add to Google Reader or Homepage

Subscribe in NewsGator Online

Subscribe in Bloglines

http://www.wikio.com


OpenLab2006.png Openlab 2007

Blogroll

Thanks for Reading...

Technorati

Add Terra Sigillata to your list of Technorati favorites!

Add ScienceBlogs to your list of Technorati favorites!

« First anniversary of DrugMonkey | Main | The Friday Fermentable: Foiled and Frustrated »

About Erleichda, co-author of The Friday Fermentable

Category: CancerErleichdaResearchThe Friday FermentableWine
Posted on: January 18, 2008 3:46 PM, by Abel Pharmboy

Erleichda is the nom de plume of a guest blogger who contributes regularly to The Friday Fermentable columns. The act of contributing a column periodically on the topic of wine is consistent with the philosophy embodied in his pseudonym, i.e., to "lighten up" (from 'Jitterbug Perfume' by Tom Robbins).

Erleichda holds a PhD in microbiology following a baccalaureate in the same discipline. Post-doctoral training was received in tumor immunology and virology. While initial employment involved transplantation immunology research for a few years, a subsequent job at a research institute focused his attention on experimental chemotherapy and tumor biology. For the past nearly 30 years, Erleichda has worked in the pharmaceutical industry as a cancer drug developer. In that time, he has contributed substantially to the evaluation and development of scores of advanced compounds, culminating in the introduction of more than a dozen drug candidates to clinical trial, and continues to shepherd several of them toward satisfying unmet medical needs. With his colleagues, Erleichda has brought many of today's well known anticancer drugs to our armamentarium against this family of diseases.

The search for new anticancer therapeutics, and interest in natural products especially, led to the meeting of Abel Pharmboy and Erleichda, who, whenever the opportunity permits, continue to work together in this vein.

When not engaged in cancer drug development, Erleichda can be found hiking in Europe, "wherever grapes grow" he says, playing bridge on-line (listening to his personalized "Billie Holiday" station on Pandora.com) while glancing outside at the peafowl he keeps, playing a few games of racquetball, collecting medieval coins, and, of course, entertaining friends while sampling many wines.

Share this: Stumbleupon Reddit Email + More

TrackBacks

TrackBack URL for this entry: http://scienceblogs.com/mt/pings/61709

Post a Comment

(Email is required for authentication purposes only. On some blogs, comments are moderated for spam, so your comment may not appear immediately.)





ScienceBlogs

Search ScienceBlogs:

Go to:

Advertisement
Follow ScienceBlogs on Twitter
Visit the Collective Imagination blog
Advertisement
Enter to win

© 2006-2009 Seed Media Group LLC. ScienceBlogs is a registered trademark of Seed Media Group. All rights reserved.

Sites by Seed Media Group: Seed Media Group | ScienceBlogs | SEEDMAGAZINE.COM